Figure 10From: Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapyMR imaging to assess intratumoral distributions of N Chitosan-DMNPs in tumor-bearing mice and comparative therapeutic efficacy. (a) T 2-weighted MR images of tumor-bearing mice after intravenous injection of N Chitosan-DMNPs. Tumor regions are indicated with a yellow line boundary. (b) Comparative therapeutic efficacy study in the in vivo model (black, N Chitosan-DMNPs; gray, DOX; white, saline). Red arrowheads indicate the therapeutic dosing schedule of each therapeutic condition (N Chitosan-DMNPs, DOX, and saline).Back to article page